Bartlett & Co Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,450
Closed -$179K 862
2020
Q2
$179K Hold
1,450
﹤0.01% 324
2020
Q1
$140K Hold
1,450
﹤0.01% 323
2019
Q4
$134K Hold
1,450
﹤0.01% 378
2019
Q3
$111K Hold
1,450
﹤0.01% 390
2019
Q2
$125K Hold
1,450
﹤0.01% 301
2019
Q1
$85.7K Hold
1,450
﹤0.01% 337
2018
Q4
$76.5K Hold
1,450
﹤0.01% 343
2018
Q3
$80.4K Hold
1,450
﹤0.01% 350
2018
Q2
$68.2K Hold
1,450
﹤0.01% 386
2018
Q1
$52.5K Buy
+1,450
New +$51K ﹤0.01% 418

Other funds holding RGEN

Bartlett & Co Wealth Management's RGEN Position: Q3 2020 in Review

Bartlett & Co Wealth Management sold out of Repligen (RGEN) in Q3 2020, closing a stake of 1,450 shares — an estimated $179K sold.

Bartlett & Co Wealth Management first reported a position in RGEN in Q1 2018 and held it in 10 quarters. The position peaked at $179K in Q2 2020. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.

  • Bartlett & Co Wealth Management reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 1,450 Repligen shares in Q3 2020, an estimated $179K.
  • Bartlett & Co Wealth Management first reported a position in Repligen in Q1 2018 and held it in 10 quarters.
  • Bartlett & Co Wealth Management's Repligen position peaked at $179K in Q2 2020.
  • 390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.

Based on Bartlett & Co Wealth Management's 13F filing for Q3 2020, filed 13 Feb 2024.